GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3051 - 3075 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 1 22 moderate
G75896PD
442
IgA Patient 3 11 mild
G86156UJ
442
IgG Patient 3 -180 mild
G51175PR
442
IgM Patient 3 -180 mild
G00057MO
442
IgA Patient 3 4 mild
G02670IJ
442
IgM Patient 3 4 mild
G32699RJ
442
IgA Patient 1 10 moderate
G68703KI
443
IgM Patient 2 24 mild
G69912LP
443
IgM Patient 2 24 mild
G91537AT
443
IgA Patient 3 11 mild
G03499BP
443
IgA Patient 3 11 mild
G22768VO
443
IgA Patient 3 11 mild
G51872EK
443
IgA Patient 4 12 mild
G72424VO
443
IgA Patient 1 10 moderate
G78255UI
444
IgA Patient 1 6 moderate
G26125KY
444
IgA Patient 2 24 mild
G36191CD
444
IgM Patient 2 3 mild
G30839DN
444
IgA Patient 2 15 mild
G72424VO
445
IgA Patient 1 6 moderate
G27689OB
446
IgA Patient 1 6 moderate
G78255UI
446
IgA Patient 2 15 mild
G14569AR
446
IgG Patient 2 3 mild
G21320TF
446
IgM Patient 2 3 mild
G98240FC
446
IgA Patient 3 11 mild
G29011JC
446
IgA Patient 4 12 mild
G58547FH
446

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024